0775 on Hong Kong Stock Exchange

CK Life Sciences

CK Life Sciences International (Holdings) Inc. (Chinese: 長江生命科技集團有限公司), or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.2 It was founded in 2000.1 It is headquartered in Hong Kong.1 Its shares trade on Hong Kong Stock Exchange under the symbol 0775.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2000Founded1

Compare with another stock.

  • Ticker0775 on Hong Kong Stock Exchange1
  • Industrybiotechnology industry1
  • HeadquartersHong Kong1
  • Websitewww.ck-lifesciences.com
  • Legal formpublic company1
CK Life Sciences
Photo: Exploringlife, CC BY-SA 4.0, via Wikimedia Commons3

CK Life Sciences International (Holdings) Inc. (Chinese: 長江生命科技集團有限公司), or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.2

Corporate structure

CK Life Sciences is part of a group headed by Cheung Kong Holdings. 40 entities, 15 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company

Owners

From Wikidata.1

Timeline

  1. 2000Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3